Healthcare disparities among anticoagulation therapies for severe COVID-19 patients in the multi-site VIRUS registry
Christian Kirkup(Nference (United States)), Venky Soundararajan(Biogen (United States)), John C. O’Horo(Mayo Clinic), Andrew D. Badley(Mayo Clinic), Colin Pawlowski(Nference (United States)), Ian Conrad(Nference (United States)), Vikas Bansal(Mayo Clinic in Florida), Howard A. Zaren(St. Joseph’s Candler Hospital), Dina Gomaa(University of Cincinnati), Arjun Puranik(Nference (United States)), Rahul Kashyap(WellSpan Health), Steven K. Daugherty(Cox Medical Center South), AJ Venkatakrishnan(Nference (United States)), И. Б. Заболотских(Kuban State Medical University), Brian Pickering(Mayo Clinic), Jarrod Mosier(University of Arizona), Michael Bernstein(Saint Louis University), Valerie Banner‐Goodspeed(Beth Israel Deaconess Medical Center)
Cited by 2
Related Papers
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
|Clinical Infectious Diseases|2020|1.1k
Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy
|JAMA|2019|370
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022)
|Clinical Infectious Diseases|2022|201
Derivation and Diagnostic Accuracy of the Surgical Lung Injury Prediction Model
|Anesthesiology|2011|189
Postoperative analgesia. Guidelines
|Annals of critical care|2019|103